Record Details


Field	Value

Title	Dolutegravir for second-line treatment: Programmatic implications of new evidence

Creator	Zhao, Ying Maartens, Gary Meintjes, Graeme

Subject	— antiretroviral therapy; HIV; dolutegravir; second-line
Description	No abstract available.

Publisher	AOSIS

Contributor	—
Date	2022-09-05

Type	info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format	text/html application/epub+zip text/xml application/pdf
Identifier	10.4102/sajhivmed.v23i1.1428

Source	Southern African Journal of HIV Medicine; Vol 23, No 1 (2022); 2 pages 2078-6751 1608-9693

Language	eng

Relation	The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article: https://sajhivmed.org.za/index.php/hivmed/article/view/1428/2854 https://sajhivmed.org.za/index.php/hivmed/article/view/1428/2855 https://sajhivmed.org.za/index.php/hivmed/article/view/1428/2856 https://sajhivmed.org.za/index.php/hivmed/article/view/1428/2857

Coverage	— — —
Rights	Copyright (c) 2022 Ying Zhao, Gary Maartens, Graeme Meintjes https://creativecommons.org/licenses/by/4.0